In contrast, AGII and AGIII presented higher GLUD1 expression levels than GBM, and particularly in those cases harboring IDH1 mutation, and a similar trend was observed at the protein level, although this observation needs to be extended for additional cases to reach statistical significance. Here, GLUD1 is linked to glioblastoma.